New Research Paper Addressing Concerns about Generic ADHD Medication / Health Canada Up-dates on the Issue

Since 2010 CADDAC has shared our concerns about the direct substitution of methylphenidate ER-C, a generic medication, for OROS® methylphenidate (Concerta) with Health Canada. This was done through documentation, caregiver and patient survey results and several face to face meetings. A Canadian research paper reviewing data on this issue, was recently published in the Clinical…

Australian School Systems Fail Students with ADHD

It was with great interest that I reviewed an Australian study looking at academic achievement in students with ADHD during the period from childhood to adolescence. Having spent the last twenty years speaking with researchers, parents, educators, school boards and Ministries of Education across Canada I firmly believe that this study highlights the same situation…

ADHD and Screen Time – What the Experts Say

Children with neurodevelopmental disorders like ADHD have been excluded from general guidelines on screen use by the Canadian Pediatric Society because children with these disorders are at greater risk for internet addiction. Dr. Umesh Jain, a Child and Adolescent Psychiatrist specializing in ADHD, believes that children with ADHD should only be in front of a…